Cyclerion Therapeutics (CYCN) Receivables - Net (2021 - 2025)
Cyclerion Therapeutics (CYCN) has 5 years of Receivables - Net data on record, last reported at $100000.0 in Q3 2025.
- For Q3 2025, Receivables - Net rose 127.27% year-over-year to $100000.0; the TTM value through Sep 2025 reached $100000.0, up 127.27%, while the annual FY2024 figure was $556000.0, N/A changed from the prior year.
- Receivables - Net reached $100000.0 in Q3 2025 per CYCN's latest filing, down from $525000.0 in the prior quarter.
- Across five years, Receivables - Net topped out at $581000.0 in Q1 2025 and bottomed at $44000.0 in Q3 2024.
- Average Receivables - Net over 5 years is $244750.0, with a median of $192500.0 recorded in 2021.
- Peak YoY movement for Receivables - Net: tumbled 57.71% in 2023, then surged 127.27% in 2025.
- A 5-year view of Receivables - Net shows it stood at $100000.0 in 2021, then dropped by 4.0% to $96000.0 in 2022, then changed by 0.0% to $96000.0 in 2023, then soared by 479.17% to $556000.0 in 2024, then plummeted by 82.01% to $100000.0 in 2025.
- Per Business Quant database, its latest 3 readings for Receivables - Net were $100000.0 in Q3 2025, $525000.0 in Q2 2025, and $581000.0 in Q1 2025.